Columbus Circle Investors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-89,132
| Closed | -$5.6M | – | 251 |
|
|
2016
Q1 | $5.6M | Buy |
89,132
+47,170
| +112% | +$2.96M | 0.05% | 207 |
|
|
2015
Q4 | $3.95M | Sell |
41,962
-40,782
| -49% | -$3.84M | 0.03% | 219 |
|
|
2015
Q3 | $6.65M | Sell |
82,744
-256,787
| -76% | -$20.6M | 0.05% | 212 |
|
|
2015
Q2 | $40.7M | Buy |
339,531
+49,971
| +17% | +$5.99M | 0.29% | 89 |
|
|
2015
Q1 | $30.2M | Sell |
289,560
-84,488
| -23% | -$8.82M | 0.21% | 114 |
|
|
2014
Q4 | $36.3M | Sell |
374,048
-197,204
| -35% | -$19.1M | 0.26% | 92 |
|
|
2014
Q3 | $44.6M | Sell |
571,252
-149,584
| -21% | -$11.7M | 0.32% | 82 |
|
|
2014
Q2 | $45.5M | Sell |
720,836
-283,509
| -28% | -$17.9M | 0.31% | 90 |
|
|
2014
Q1 | $67.4M | Buy |
1,004,345
+346,036
| +53% | +$23.2M | 0.45% | 64 |
|
|
2013
Q4 | $42.3M | Sell |
658,309
-300,008
| -31% | -$19.3M | 0.29% | 96 |
|
|
2013
Q3 | $61.3M | Buy |
958,317
+342,395
| +56% | +$21.9M | 0.43% | 72 |
|
|
2013
Q2 | $19.1M | Buy |
+615,922
| New | +$19.1M | 0.15% | 156 |
|